ProfessorAlan Spivey
Vice-Provost (Education and Student Experience)
Office of the Provost - Central Faculty
Orcid identifier0000-0001-5114-490X (opens in a new tab)
- Vice-Provost (Education and Student Experience)Office of the Provost - Central Faculty
- 020 7594 5841 (Work)
- 501C, Molecular Sciences Research Hub, White City Campus, United Kingdom
RESEARCH
Overview
Grant support from the following agencies:
EPSRC, BBSRC, MRC, DTI-Smart, Wellcome Trust, Leverhulme Trust, CRUK
Collaborative support from the following companies:
AstraZeneca, GlaxoSmithKline, Novartis, Roche, Sanofi-Aventis, Pfizer, Syngenta, Bayer Cropscience, GE Healthcare, Avecia
Total synthesis of bioactive natural products: anti-tumour Amaryllidaceae alkaloids, anti-HIV Celastraceae sesquiterpenoids and anti-asthma macrolides
Development of asymmetric nucleophilic organocatalysts for acylation of alcohols and amines
Development of organogermanium chemistry for use in novel parallel synthesis linkers
Novel methods for supported-synthesis of isotopically labeled compounds for e.g. Positron Emission Tomography (PET)
Development of antagonists to protein-protein interactions - IgE/high affinity receptor
The interactions of thiols with nitric oxide - S-nitrosothiol and sulfenic acid chemistry
Development of nuclear receptor protein regulators as potential anti-cancer therapeutic leads
Grant support from the following agencies:
EPSRC, BBSRC, MRC, DTI-Smart, Wellcome Trust, Leverhulme Trust, CRUK
Collaborative support from the following companies:
AstraZeneca, GlaxoSmithKline, Novartis, Roche, Sanofi-Aventis, Pfizer, Syngenta, Bayer Cropscience, GE Healthcare, Avecia
Total synthesis of bioactive natural products: anti-tumour Amaryllidaceae alkaloids, anti-HIV Celastraceae sesquiterpenoids and anti-asthma macrolides
Development of asymmetric nucleophilic organocatalysts for acylation of alcohols and amines
Development of organogermanium chemistry for use in novel parallel synthesis linkers
Novel methods for supported-synthesis of isotopically labeled compounds for e.g. Positron Emission Tomography (PET)
Development of antagonists to protein-protein interactions - IgE/high affinity receptor
The interactions of thiols with nitric oxide - S-nitrosothiol and sulfenic acid chemistry
Development of nuclear receptor protein regulators as potential anti-cancer therapeutic leads